Drug Interactions News

Parkinson's disease is an explicit qualifying condition for Minnesota's medical cannabis program. This 2026 guide covers the clinical evidence for tremor, REM Sleep Behavior Disorder, and pain, along with critical drug interactions with levodopa, MAO-B inhibitors, and dopamine agonists — and why CBD-dominant products are the safest starting point for most Parkinson's patients.

Osteoarthritis and rheumatoid arthritis involve different mechanisms and respond differently to cannabis. This 2026 guide covers the endocannabinoid system in joint tissue, clinical evidence, drug interactions with methotrexate and JAK inhibitors, product recommendations by arthritis type, and how Minnesota patients can qualify for a medical card.

Many adults with ADHD turn to cannabis for symptom relief, but what does the research actually show? This guide covers ECS-ADHD biology, drug interactions with stimulants and Strattera, whether ADHD qualifies for a Minnesota medical card, and evidence-based guidance for adults considering cannabis.

Adults 65 and older are the fastest-growing cannabis consumer segment. This guide covers how aging changes your cannabis experience, the strongest evidence for chronic pain, arthritis, sleep, and anxiety, drug interactions seniors must know (warfarin, blood thinners, sedatives), best product types, dosing guidance, Minnesota qualifying conditions for a medical card, and how to navigate a dispensary for the first time.

Older adults are the fastest-growing cannabis demographic in Minnesota. Here's what seniors need to know about medical cards, drug interactions, the right products, nursing homes, Medicare, and how to start safely in 2026.